Annelisa M Cornel

11PUBLICATIONS
31CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomaterialsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 06, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function.

Nils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese

|Apr 01, 2024
Thymic NK-Cells and Their Potential in Cancer Immunotherapy.

Caitlyn Forbes, Stefan Nierkens, Annelisa M Cornel

|Mar 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.

Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter

|Jul 21, 2023
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.

Marjolein C Stip, Mitchell Evers, Maaike Nederend

|Dec 15, 2022
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch.

Annelisa M Cornel, Ester Dunnebach, Damon A Hofman

|Sep 28, 2021
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression.

Josephine G M Strijker, Ronja Pscheid, Esther Drent

Pageof 2